bioAffinity Technologies, Inc.
Ticker: 1712762
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 1.35-6.9% | 1.45+14.2% | 1.27-31.4% | 1.85-21.3% | 2.35-2.1% | 2.40-0.4% | 2.41+703.3% | 0.30 |
| Total Income | 1.35-6.9% | 1.45+14.2% | 1.27-31.4% | 1.85-21.3% | 2.35-2.1% | 2.40-0.4% | 2.41+703.3% | 0.30 |
| EXPENSES | ||||||||
| Expenditure | 4.97+32.9% | 3.74-1.3% | 3.79-15.4% | 4.48+3.7% | 4.32-3.8% | 4.49+3.2% | 4.35+68.0% | 2.59 |
| Tax | — | 0.00-100.0% | 0.03+200.0% | 0.01 | 0.00-100.0% | 0.01 | 0.00 | 0.00 |
| PROFIT | ||||||||
| PBT | -3.63+28.1% | -5.05-25.3% | -4.03-52.1% | -2.65-32.5% | -2.00+4.8% | -2.10-7.1% | -1.96+14.4% | -2.29 |
| Net Profit | -3.63+28.1% | -5.05-24.4% | -4.06-52.6% | -2.66-33.0% | -2.00+5.2% | -2.11-7.7% | -1.96+14.4% | -2.29 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00%-16.02pp | -83.98%+3.10pp | -87.08%-6.24pp | -80.84%+19.16pp | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00%-14.87pp | -85.13%+2.89pp | -88.01%-6.49pp | -81.53%+18.47pp | -100.00% |
| EPS | -0.81+82.9% | -4.74-2688.2% | -0.17-6.3% | -0.16+0.0% | -0.16+15.8% | -0.19+5.0% | -0.20+23.1% | -0.26 |
Corporate Events
Board MeetingBIAF
202630Apr
Board Meeting
Approval of Amendment to 2024 Equity Incentive Compensation …
SEC Filing ↗